🇺🇸 FDA
Pipeline program

Bexarotene/NBUVB vs placebo NBUVB

4405

Phase 2 small_molecule completed

Quick answer

Bexarotene/NBUVB vs placebo NBUVB for Psoriasis is a Phase 2 program (small_molecule) at LIGAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
LIGAND PHARMACEUTICALS INC
Indication
Psoriasis
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials